IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q3 2023 Holdings

Filed 2023-11-14 | 13 holdings | $217.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corp(LQDA)COM NEW53635D202$58.6M9,243,62726.9%
Alimera Sciences IncCOM NEW016259202$52.2M16,835,15424.0%
Intercept Pharmaceuticals IncPutPUT45845P958$22.2M1,200,00010.2%
Standard Biotools Inc(LAB)COM34385P108$22.1M7,622,41310.2%
Anika Therapeutics Inc(ANIK)COM035255108$20.1M1,081,3609.3%
Exelixis Inc(EXEL)COM30161Q104$19.9M910,7309.1%
Evolus Inc(EOLS)COM30052C107$15.4M1,683,8367.1%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$3.0M183,0641.4%
Adma Biologics Inc(ADMA)COM000899104$2.1M597,5131.0%
Verrica Pharmaceuticals IncCOM92511W108$1.0M259,5930.5%
Societal Cdmo IncCOM75629F109$794.2K1,689,7680.4%
Y-Mabs Therapeutics Inc(YMABUSD)COM984241109$127.1K23,3210.1%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$119.6K4,8330.1%